McDermott Will & Emery represented Iron Path Capital, while Spilman Thomas & Battle represented Chemours in the transaction. PureTech Scientific announced the acquisition of The Chemours Company’s...
PureTech Scientific’s $137 Million Acquisition of The Chemours Company’s Glycolic Acid Business
Iron Path Capital’s Partnership With Capitol Pain Institute
McDermott Will & Emery represented Iron Path Capital in the transaction. Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, announced its...